Literature DB >> 10445806

HIV type 1 genetic variability in the northern part of Cameroon.

I Mboudjeka1, L Zekeng, J Takehisa, T Miura, E Ido, M Yamashita, L Kaptue, M Hayami.   

Abstract

In 1995, 53 blood samples from Muslim patients with AIDS, or who were thought to have AIDS, were collected in the main hospitals of Adamaoua Province, in the northern part of Cameroon. The variable env C2V3 region of HIV-1 was amplified by nested PCR and phylogenetically analyzed. The results indicated that of 15 amplified samples, 1 belonged to HIV-1 group O, 1 to HIV-1 subtype D, 1 to subtype G, 2 to subtype H, and 10 to subtype A. Furthermore, the northern Cameroonian subtype A could be divided into at least two subclusters as shown by the env tree as well as by two remarkably conserved hexameric amino acid sequences in the apex of V3 (GPGQAF in one subcluster and GPGQTF in the other). This distinction suggests that the HIV-1 subtype A circulating in northern Cameroon evolved from two main sources. More recently, three HIV-1 strains from Nigeria (IBNG) and Djibouti (DJ263 and DJ264), previously reported on the basis of their env C2V3 sequences as subtype A, were found to have a similar A/G mosaic structure alongside their full-length sequence and were tentatively designated as members of a new subtype called "IBNG." Interestingly, within the northern Cameroonian subtype A described, the isolates of the second subcluster clustered distinctly with these A/G mosaic strains, strongly suggesting that they may be members of the IBNG subtype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445806     DOI: 10.1089/088922299310458

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking.

Authors:  Chavdar Krachmarov; Abraham Pinter; William J Honnen; Miroslaw K Gorny; Phillipe N Nyambi; Susan Zolla-Pazner; Samuel C Kayman
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon.

Authors:  J Takehisa; L Zekeng; E Ido; Y Yamaguchi-Kabata; I Mboudjeka; Y Harada; T Miura; L Kaptu; M Hayami
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 3.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

4.  New infections and HIV-1 subtypes among febrile persons and blood donors in Oyo State, Nigeria.

Authors:  Babatunde A Olusola; David O Olaleye; Georgina N Odaibo
Journal:  J Med Virol       Date:  2021-03-01       Impact factor: 20.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.